Gossamer Bio, Inc. (GOSS)

Gossamer Bio has collapsed from $288 to $10.69 over the past year, and a reverse stock split takes effect September 10. The stock bounced sharply off lows near $9 in late July and again in late August, but both rallies stalled below $18. Right now it's trading near the bottom of its recent range, which makes the next move worth watching.

The long-term picture

Over the past year, GOSS has traced a brutal downtrend from $288 to its current $10.69—a 96% loss. The stock found a low of $9.10 in mid-July, then rallied to $21.46 by the end of that month. That bounce didn't hold. A second attempt to climb higher in late August peaked at $17.10 before rolling over again. The pattern shows the stock is oscillating between a floor near $9–$11 and a ceiling around $17–$21, with each rally failing to break higher.

Price is now sitting at the very bottom of this recent trading band, just 1.2% above the lowest close of the past few months. The earnings beat on August 13 provided a brief lift, but momentum didn't sustain. The reverse split, effective September 10, will adjust the share count but doesn't change the underlying business or the technical picture—it's a mechanical adjustment that will reset the nominal price higher while preserving the percentage moves.

The short-term picture

On the 4-hour chart, the stock has been grinding lower over the past week. It closed at $14.50 a week ago and has fallen 26% to $10.69, now sitting just 1.2% above the lowest close in this shorter timeframe. The recent swings show a low of $11.99 on September 9 and a high of $14.75 on September 8—a tight, downward-sloping range.

Resistance sits at $13.56, about 27% above the current price. Support is at $9.10, the same level that held in July and August. The 4-hour view and weekly view are aligned: both are pointing downward. Momentum is weak, and price is near the lower edge of its recent band. A break below $9.10 would signal a new low and extend the downtrend; a sustained move above $13.56 would be needed to suggest the bounce pattern is resuming.

What's driving it

Gossamer Bio beat earnings expectations by 18% on August 13, which is marked on both charts. That beat didn't spark a sustained rally—the stock peaked two weeks later and has since retreated. The more immediate catalyst is the reverse stock split effective September 10. This is a 1-for-80 split, meaning every 80 shares become 1 share at 80 times the nominal price. It's a structural change, not a fundamental one, but it will reset the price scale and may affect how the stock trades in the days immediately following the adjustment.

What would change this

A break below $9.10 would invalidate the current support level and suggest the downtrend is accelerating into new lows. That would shift the picture from a stock bouncing between defined bands to one breaking down further. Conversely, a sustained move above $13.56 on the 4-hour chart, followed by a close above $17.10 on the weekly chart, would signal that the bounce pattern is resuming and that the stock is attempting to climb out of its recent range. Either move would need to hold for several periods to confirm a real shift in direction.

Key takeaways

• GOSS has fallen 87% from its $288 high and is now trading at the bottom of a $9–$21 range established over the past two months.
• Two rallies in July and August both stalled below $18, and the stock is now 27% below the nearest resistance level at $13.56.
• Support at $9.10 has held twice; a break below it would signal a new downtrend, while a move above $13.56 would suggest the bounce pattern is resuming.
• The reverse stock split effective September 10 is a mechanical adjustment that will reset the nominal price but does not change the technical or fundamental picture.